Medicine compound made of haw leaf and rhodiola
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGYIN TIANJIANG PHARMA
- Publication Date
- 2007-09-26
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1
Abstract
Description
[technical field]
[0001] The invention belongs to the technical field of medicine, and relates to a pharmaceutical composition of hawthorn leaf or its extract and rhodiola rosea or its extract for treating cardiovascular and cerebrovascular diseases, a preparation containing the pharmaceutical composition and a preparation method thereof. [Background technique]
[0002] Cardiovascular and cerebrovascular disease is a common disease that seriously threatens the health of middle-aged and elderly people, and is known as the "first killer" of human health. According to my country's epidemiological survey, the percentage of deaths from cardiovascular and cerebrovascular diseases in the total death population in my country has risen from 12.07% in 1957 to 42.6% in 2001, and 2 million people die from cardiovascular and cerebrovascular diseases every year. Therefore, to reveal the mechanism of the occurrence and development of cardiovascular and cerebrovascular diseases, to carry ou...